# CHECKMATE PHARMACEUTICALS IN (CMPI)

> Institutional ownership reported to the SEC as of Q1 2022, from Form 13F filings. Source: https://holderbook.com/stocks/CMPI/

- Reporting holders: 23
- Reported value: $54.8M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [venBio Partners LLC](https://holderbook.com/funds/1776382-venbio-partners-llc/) | $11.7M | 3,673,374 | 2.6% | 7 |
| [Sofinnova Investments, Inc.](https://holderbook.com/funds/1631134-sofinnova-investments-inc/) | $11.5M | 3,606,707 | 0.9% | 7 |
| [Novo Holdings A/S](https://holderbook.com/funds/1388325-novo-holdings-a-s/) | $6.9M | 2,161,990 | 0.4% | 7 |
| [Medicxi Ventures Management (Jersey)  Ltd](https://holderbook.com/funds/1715579-medicxi-ventures-management-jersey-ltd/) | $4.8M | 1,501,716 | 1.3% | 7 |
| [Omega Fund Management, LLC](https://holderbook.com/funds/1637359-omega-fund-management-llc/) | $4.3M | 1,335,050 | 0.9% | 7 |
| [Decheng Capital Management III (Cayman), LLC](https://holderbook.com/funds/1747821-decheng-capital-management-iii-cayman-llc/) | $4.3M | 1,333,254 | 1.3% | 1 |
| [Clough Capital Partners L P](https://holderbook.com/funds/1276144-clough-capital-partners-l-p/) | $3.6M | 1,137,764 | 0.3% | 7 |
| [FMR LLC](https://holderbook.com/funds/315066-fmr-llc/) | $3.1M | 966,226 | 0.0% | 7 |
| [VANGUARD GROUP INC](https://holderbook.com/funds/102909-vanguard-group-inc/) | $1.8M | 556,423 | 0.0% | 7 |
| [SECTORAL ASSET MANAGEMENT INC](https://holderbook.com/funds/1274413-sectoral-asset-management-inc/) | $1.7M | 541,765 | 0.3% | 7 |
| [BRIDGEWAY CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1107261-bridgeway-capital-management-llc/) | $340.0K | 106,500 | 0.0% | 5 |
| [RBF Capital, LLC](https://holderbook.com/funds/1134621-rbf-capital-llc/) | $219.0K | 68,034 | 0.0% | 4 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $164.0K | 51,334 | 0.0% | 7 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $132.0K | 41,466 | 0.0% | 7 |
| [FEDERATED HERMES, INC.](https://holderbook.com/funds/1056288-federated-hermes-inc/) | $98.0K | 30,636 | 0.0% | 7 |
| [CAMBRIDGE TRUST CO](https://holderbook.com/funds/1074272-cambridge-trust-co/) | $79.0K | 24,609 | 0.0% | 5 |
| [BARCLAYS PLC](https://holderbook.com/funds/312069-barclays-plc/) | $46.0K | 14,553 | 0.0% | 1 |
| [STATE STREET CORP](https://holderbook.com/funds/93751-state-street-corp/) | $36.0K | 11,424 | 0.0% | 3 |
| [MORGAN STANLEY](https://holderbook.com/funds/895421-morgan-stanley/) | $10.0K | 3,005 | 0.0% | 7 |
| [US BANCORP \DE\](https://holderbook.com/funds/36104-us-bancorp-de/) | $6.0K | 2,000 | 0.0% | 4 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $6.0K | 1,940 | 0.0% | 1 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $1.0K | 183 | 0.0% | 7 |
| [Johnson Midwest Financial, LLC](https://holderbook.com/funds/1732399-johnson-midwest-financial-llc/) | $1.0K | 200 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q1 2022 | 23 | $54.8M |
| Q4 2021 | 23 | $46.3M |
| Q3 2021 | 30 | $64.6M |
| Q2 2021 | 31 | $97.3M |
| Q1 2021 | 37 | $202.5M |
| Q4 2020 | 36 | $235.9M |
| Q3 2020 | 37 | $187.4M |